In vivo inhibition of adenosine deaminase by 2'-deoxycoformycin in mouse blood and leukemia L1210 cells

Ram P. Agarwal

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Adenosine deaminase (ADA) activities in mouse whole blood, washed erythrocytes and L1210 cells were 0.48, 0.93 and 4.76 units/ml respectively. Methods were developed to determine the second-order association rate constant (k1) of a tight-binding ADA inhibitor, deoxycoformycin (DCF), and ADA in mouse blood and L1210 cells in vivo. After i.v. injection of DCF, the inhibition of the enzyme was of a monophasic pseudo-first-order nature in blood and biphasic (with an initial lag of 3-5 min) in L1210 cells. In contrast, i.p. injection of DCF produced the opposite pattern, monophasic in L1210 cells and biphasic in blood. The apparent k1 values determined from the linear portions of these curves were compared with the k1 values obtained in vitro. The mean k1 values in vivo were: 4.2 × 104 and 1.4 × 104M-1 sec-1 in blood after i.v. and i.p. injections, respectively, and 2.6 × 103 and 2.2 × 104 M-1 sec-1 in L1210 cells after i.v. and i.p. injections respectively. The k1 values with either whole blood or L1210 in vitro (3.1 × 104 and 5.5 × 103 M-1 sec-1, respectively) were of the same order of magnitude as those obtained with these tissues in vivo. In contrast, the k1 values were about 150 to 1400-fold higher when either blood hemolysates (4.8 x 10-6M-1 sec-1) or homogenized L1210 cells (7.5 x 106-1 sec-1) were used. The 150 to 1400-fold higher k1 values for blood hemolysates and homogenized L1210 cells than for intact cell samples (whole blood or whole L1210 ascitic fluid) suggest that the cell membrane plays a role in the interaction of DCF and ADA in these cell lines. The similarity of the rates of association of DCF and ADA in vivo and in vitro for mouse blood and ascites L1210 cells suggests that data obtained in vitro may be used to estimate the k1 values in in vivo conditions.

Original languageEnglish
Pages (from-to)187-193
Number of pages7
JournalBiochemical Pharmacology
Volume29
Issue number2
DOIs
StatePublished - Jan 15 1980
Externally publishedYes

Fingerprint

Pentostatin
Leukemia L1210
Adenosine Deaminase
Blood
Injections
Adenosine Deaminase Inhibitors
Ascitic Fluid
Ascites
Cell membranes
Blood Cells
Erythrocytes
Rate constants
Cell Membrane
Cells
Association reactions

ASJC Scopus subject areas

  • Pharmacology

Cite this

In vivo inhibition of adenosine deaminase by 2'-deoxycoformycin in mouse blood and leukemia L1210 cells. / Agarwal, Ram P.

In: Biochemical Pharmacology, Vol. 29, No. 2, 15.01.1980, p. 187-193.

Research output: Contribution to journalArticle

@article{f0e612ed59754239928d8c92c8ab5bd9,
title = "In vivo inhibition of adenosine deaminase by 2'-deoxycoformycin in mouse blood and leukemia L1210 cells",
abstract = "Adenosine deaminase (ADA) activities in mouse whole blood, washed erythrocytes and L1210 cells were 0.48, 0.93 and 4.76 units/ml respectively. Methods were developed to determine the second-order association rate constant (k1) of a tight-binding ADA inhibitor, deoxycoformycin (DCF), and ADA in mouse blood and L1210 cells in vivo. After i.v. injection of DCF, the inhibition of the enzyme was of a monophasic pseudo-first-order nature in blood and biphasic (with an initial lag of 3-5 min) in L1210 cells. In contrast, i.p. injection of DCF produced the opposite pattern, monophasic in L1210 cells and biphasic in blood. The apparent k1 values determined from the linear portions of these curves were compared with the k1 values obtained in vitro. The mean k1 values in vivo were: 4.2 × 104 and 1.4 × 104M-1 sec-1 in blood after i.v. and i.p. injections, respectively, and 2.6 × 103 and 2.2 × 104 M-1 sec-1 in L1210 cells after i.v. and i.p. injections respectively. The k1 values with either whole blood or L1210 in vitro (3.1 × 104 and 5.5 × 103 M-1 sec-1, respectively) were of the same order of magnitude as those obtained with these tissues in vivo. In contrast, the k1 values were about 150 to 1400-fold higher when either blood hemolysates (4.8 x 10-6M-1 sec-1) or homogenized L1210 cells (7.5 x 106-1 sec-1) were used. The 150 to 1400-fold higher k1 values for blood hemolysates and homogenized L1210 cells than for intact cell samples (whole blood or whole L1210 ascitic fluid) suggest that the cell membrane plays a role in the interaction of DCF and ADA in these cell lines. The similarity of the rates of association of DCF and ADA in vivo and in vitro for mouse blood and ascites L1210 cells suggests that data obtained in vitro may be used to estimate the k1 values in in vivo conditions.",
author = "Agarwal, {Ram P.}",
year = "1980",
month = "1",
day = "15",
doi = "10.1016/0006-2952(80)90327-5",
language = "English",
volume = "29",
pages = "187--193",
journal = "Biochemical Pharmacology",
issn = "0006-2952",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - In vivo inhibition of adenosine deaminase by 2'-deoxycoformycin in mouse blood and leukemia L1210 cells

AU - Agarwal, Ram P.

PY - 1980/1/15

Y1 - 1980/1/15

N2 - Adenosine deaminase (ADA) activities in mouse whole blood, washed erythrocytes and L1210 cells were 0.48, 0.93 and 4.76 units/ml respectively. Methods were developed to determine the second-order association rate constant (k1) of a tight-binding ADA inhibitor, deoxycoformycin (DCF), and ADA in mouse blood and L1210 cells in vivo. After i.v. injection of DCF, the inhibition of the enzyme was of a monophasic pseudo-first-order nature in blood and biphasic (with an initial lag of 3-5 min) in L1210 cells. In contrast, i.p. injection of DCF produced the opposite pattern, monophasic in L1210 cells and biphasic in blood. The apparent k1 values determined from the linear portions of these curves were compared with the k1 values obtained in vitro. The mean k1 values in vivo were: 4.2 × 104 and 1.4 × 104M-1 sec-1 in blood after i.v. and i.p. injections, respectively, and 2.6 × 103 and 2.2 × 104 M-1 sec-1 in L1210 cells after i.v. and i.p. injections respectively. The k1 values with either whole blood or L1210 in vitro (3.1 × 104 and 5.5 × 103 M-1 sec-1, respectively) were of the same order of magnitude as those obtained with these tissues in vivo. In contrast, the k1 values were about 150 to 1400-fold higher when either blood hemolysates (4.8 x 10-6M-1 sec-1) or homogenized L1210 cells (7.5 x 106-1 sec-1) were used. The 150 to 1400-fold higher k1 values for blood hemolysates and homogenized L1210 cells than for intact cell samples (whole blood or whole L1210 ascitic fluid) suggest that the cell membrane plays a role in the interaction of DCF and ADA in these cell lines. The similarity of the rates of association of DCF and ADA in vivo and in vitro for mouse blood and ascites L1210 cells suggests that data obtained in vitro may be used to estimate the k1 values in in vivo conditions.

AB - Adenosine deaminase (ADA) activities in mouse whole blood, washed erythrocytes and L1210 cells were 0.48, 0.93 and 4.76 units/ml respectively. Methods were developed to determine the second-order association rate constant (k1) of a tight-binding ADA inhibitor, deoxycoformycin (DCF), and ADA in mouse blood and L1210 cells in vivo. After i.v. injection of DCF, the inhibition of the enzyme was of a monophasic pseudo-first-order nature in blood and biphasic (with an initial lag of 3-5 min) in L1210 cells. In contrast, i.p. injection of DCF produced the opposite pattern, monophasic in L1210 cells and biphasic in blood. The apparent k1 values determined from the linear portions of these curves were compared with the k1 values obtained in vitro. The mean k1 values in vivo were: 4.2 × 104 and 1.4 × 104M-1 sec-1 in blood after i.v. and i.p. injections, respectively, and 2.6 × 103 and 2.2 × 104 M-1 sec-1 in L1210 cells after i.v. and i.p. injections respectively. The k1 values with either whole blood or L1210 in vitro (3.1 × 104 and 5.5 × 103 M-1 sec-1, respectively) were of the same order of magnitude as those obtained with these tissues in vivo. In contrast, the k1 values were about 150 to 1400-fold higher when either blood hemolysates (4.8 x 10-6M-1 sec-1) or homogenized L1210 cells (7.5 x 106-1 sec-1) were used. The 150 to 1400-fold higher k1 values for blood hemolysates and homogenized L1210 cells than for intact cell samples (whole blood or whole L1210 ascitic fluid) suggest that the cell membrane plays a role in the interaction of DCF and ADA in these cell lines. The similarity of the rates of association of DCF and ADA in vivo and in vitro for mouse blood and ascites L1210 cells suggests that data obtained in vitro may be used to estimate the k1 values in in vivo conditions.

UR - http://www.scopus.com/inward/record.url?scp=0018844209&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018844209&partnerID=8YFLogxK

U2 - 10.1016/0006-2952(80)90327-5

DO - 10.1016/0006-2952(80)90327-5

M3 - Article

VL - 29

SP - 187

EP - 193

JO - Biochemical Pharmacology

JF - Biochemical Pharmacology

SN - 0006-2952

IS - 2

ER -